Editorial Staff

Clinical Editor
Morton Kern, MD
Executive Editor
Laurie Gustafson
Managing Editor
Rebecca Kapur
Production Manager
Elizabeth Vasil

Editorial Correspondence

Rebecca Kapur, Managing Editor, Cath Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (440) 717-0418

Fax: (866) 896-8762
Email: rkapur@hmpglobal.com

January 2014

Volume 1 Issue 22
MitraClip has been approved for patients with significant symptomatic degenerative mitral regurgitation (MR) who are at prohibitive risk for mitral valve surgery.
Our experience is good. Ninety percent (90%) of patients treated so far have had successful thrombolysis of their obstructed deep iliac veins; the majority in < 24 hrs.
Multidisciplinary decision-making is gaining traction in many areas of cardiovascular medicine, including aortic and mitral valve disease, and ischemic heart disease. The multidisciplinary approach facilitates selecting the optimal treatment option f…
Due to the location and severity of the disease in the SVG to the circumflex artery, the procedure was stopped, and a multi-disciplinary strategy was coordinated to revascularize the patient.
My cardiology fellow said we should now stent the RCA since we were already here and the patient was quite stable. I demurred and said we will be back in a couple weeks unless the patient develops angina. The RCA could be treated after recovery from…